静脉中毒的诊断和治疗挑战:一个案例报告
Shivani S Bothara1, Pratapsingh Parihar1, Ravishankar Patil1
1Radiodiagnosis, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|August 12, 2024
概括
本案例研究详细介绍了一例罕见的入静脉中毒病例,该病例发生在患有状细胞贫血的患者身上. 及时诊断和多学科护理导致了显著的临床改善.
科学领域:
- 毒理学 毒理学 毒理学
- 内部医学 内部医学
- 血液学 血液学 血液学
背景情况:
- 静脉中毒是一种罕见的,严重的医疗紧急情况.
- 意外暴露或故意自我伤害是常见的原因.
- 细胞贫血会使毒性的诊断复杂化.
研究的目的:
- 在患有状细胞贫血的患者中呈现静脉中毒病例.
- 突出诊断挑战和管理策略.
- 强调多学科方法的重要性.
主要方法:
- 一个30岁的男性患有状细胞贫血,呈现出毒性症状的病例报告.
- 诊断评估包括血清水平测量和高分辨率计算机断层扫描 (HRCT).
- 治疗包括使用抗毒剂,非侵入性通风和输血.
主要成果:
- 通过显著升高的血清含量证实了诊断.
- 在HRCT中发现了沉积物和气泡肺损伤.
- 患者在适当的管理下显示出显著的临床改善.
结论:
- 静脉中毒具有独特的诊断挑战,特别是在患有状细胞贫血等潜在疾病的患者中.
- 综合,多学科的方法对于有效的管理和最佳的患者结果至关重要.
- 早期识别和干预是改善严重毒性病例预后的关键.
相关概念视频
Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...


